Table 1 Literature main findings for CRL4CRBN-thalidomide interaction and induced protein effect.

From: CRL4-Cereblon complex in Thalidomide Embryopathy: a translational investigation

Pubmed ID

Protein Interaction

IMiD tested in the study

Is the mechanism IMiD dependent?

IMiD-protein interaction effect*

27142104

AGO2

lenalidomide

yes

alters expression.

26990986

GS

none

no

 

27294876

CD147

none, Thal, Len, Pom

no

competition for CRBN binding reduces expression

27294876

MCT1

none, Thal, Len, Pom

no

competition for CRBN binding reduces expression

26021757

CLC1

none

no

 

19295130

DDA1

none

no

 

24292623

IKZF1

Thal, Len, Pom

yes

induced degradation

24292623

IKZF3

Thal, Len, Pom

yes

induced degradation

27468689

TAB2

none

no

 

27468689

TRAF6

none

no

 

25043012

MEIS2

lenalidomide

no

block MEIS2 binding to CRBN

21232561

AMPKA1

none

no

 

23026050

PSMB4

none

no

 

27601648

RABGEF1

lenalidomide

no

prevents association to CRBN

31591562

TP63

thalidomide

yes

neosubstrate of thalidomide-CRBN

30067223

SALL4

Thal, Len, Pom

yes

thalidomide-CRBN induced degradation (C2H2 motif)

  1. Thal: thalidomide; Len: lenalidomide; Pom: pomalidomide; *differential mechanism in presence or absence of the IMiD.